Source link : https://www.newshealth.biz/health-news/transplantation-fails-to-improve-survival-in-mantle-cell-lymphoma/
SAN DIEGO — Patients with mantle cell lymphoma (MCL) and undetectable minimal residual disease (uMRD) after induction therapy did not live longer if they underwent hematopoietic cell transplantation (HCT), a randomized trial showed. After a median follow-up of 2.7 years, patients treated with rituximab (Rituxan) and transplantation had a 3-year overall survival (OS) of 82.1% […]
Author : News Health
Publish date : 2024-12-10 18:12:15
Copyright for syndicated content belongs to the linked Source.